Cargando…
A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
The anticonvulsant drug lamotrigine (LTG), a sodium channel blocker and inhibitor of glutamate release, has been found to have antidepressant effects in the treatment of bipolar disorder. It is recommended by certain therapy guidelines as a first-line agent for acute and maintenance therapy in bipol...
Autores principales: | Tränkner, Anja, Sander, Christian, Schönknecht, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554228/ https://www.ncbi.nlm.nih.gov/pubmed/23378766 http://dx.doi.org/10.2147/NDT.S37126 |
Ejemplares similares
-
The role of lamotrigine in the management of bipolar disorder
por: Ng, Felicity, et al.
Publicado: (2007) -
Manic Episode Induced by Lamotrigine in Rapid Cycling Bipolar Disorder
por: Ramos, Ana Lúcia, et al.
Publicado: (2021) -
Long-term efficacy and safety of lamotrigine for all types of bipolar disorder
por: Watanabe, Yoshinori, et al.
Publicado: (2017) -
The Cost-effectiveness of Lamotrigine in the Maintenance Treatment of Adults With Bipolar I Disorder
por: Calvert, Neill W., et al.
Publicado: (2006) -
Delayed Stevens–Johnson Syndrome Secondary to the Use of Lamotrigine in Bipolar Mood Disorder
por: Jha, Kunal Kishor, et al.
Publicado: (2017)